IGO – UBS rates the stock as Buy

IGO has announced consistent first production of battery-grade lithium hydroxide at its Kwinana Lithium Hydroxide factory.

UBS says this is a key de-risking event for the TLEA joint venture.

The broker updates realised spodumene price forecasts (-1.7% in FY22 and -11.3% in FY23) and remains structurally bullish on lithium and nickel in the medium and long term.

Upgrade to Buy from Neutral given the recent share-price retreat. Target price dips to $12.15 from $12.40.

Sector: Materials.

 

Target price is $12.15.Current Price is $11.66. Difference: $0.49 – (brackets indicate current price is over target). If IGO meets the UBS target it will return approximately 4% (excluding dividends, fees and charges – negative figures indicate an expected loss).

 

 

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →